Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816601) titled 'Donor Breast Milk 2' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: AdventHealth

Condition: Iron Deficiency Anemia

Intervention: Drug: Ferrous Sulfate Oral Product

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: May 6, 2026

Target Sample Size: 17

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07816601

Published by HT Digital Content Services with permission from Health Daily Digest....